A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

This was a phase I/II study testing the feasibility of a vaccine by autologous leukemic apoptotic corpse-pulsed dendritic cells (DC) in elderly acute myeloid leukemia (AML) patients in first or second complete remission. Pulsed DC were administered at doses of 9 × 106 subcutaneously (1 mL) and 1 × 1...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Patrice Chevallier, Soraya Saiagh, Virginie Dehame, Thierry Guillaume, Pierre Peterlin, Sylvain Bercegeay, Yannick Le Bris, Céline Bossard, Isabelle Gauvrit, Brigitte Dreno, Nadine Juge-Morineau, Marie C. Béné, Marc Gregoire
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2021-10-01
Serie:	Human Vaccines & Immunotherapeutics
Soggetti:	dendritic cells vaccine aml apoptotic corpses
Accesso online:	http://dx.doi.org/10.1080/21645515.2021.1943991
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!